Back in April we announced that
Spedra was expected to be available soon in Europe. The medication for patients
with erectile dysfunction is owned by the pharmaceutical company Vivus and in
the US is called Stendra.
Vivus has claimed that this medication
is effective within as little as 15 minutes. This month the company has published
the results of the study and it has confirmed that the drug has does indeed
have this rapid onset. Patients on this treatment actually achieved erections
in as little as 10 minutes.
The active ingredient in this medication is
called Avanafil and it acts as any other PDE5 inhibitor. Specifically, this
type of medication relaxes and opens the blood vessels in the penis, causing the
blood to enter the organ and distend it. Since it takes much less time for
Avanafil to be effective (compared with Viagra and any other PDE5 inhibitor),
many men might prefer it once it is actually on the market. We will keep you
updated on the progress of getting this medication onto the European market,
which is expected to be later this year.
More information can be read here.